De Novo
DEN160014: remOVE System
FDA De Novo · ovesco endoscopy ag · decided Dec 22, 2017
Key facts
| De Novo number | DEN160014 |
|---|---|
| Device name | remOVE System |
| Applicant | ovesco endoscopy ag |
| Product code | QAG |
| Date received | Apr 11, 2016 |
| Decision date | Dec 22, 2017 |
| Decision | granted (DENG) |
| FDA classification | Class II |
| Review panel | Gastroenterology & Urology |
| FEI number | 3006696607 |
At a glance
- None Later 510(k)s citing this De Novo
- 1–9 UDI device identifiers (GUDID)
- None MAUDE adverse event reports
- None Recall events
- No Decision summary on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About De Novo classification requests
The De Novo pathway classifies novel low- to moderate-risk devices that have no legally marketed predicate; each granted request creates a new classification regulation and product code.
Source: U.S. Food and Drug Administration (FDA), De Novo database · Source date: